Supplementary Table 2 from PIK3CA Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials
| Autor: | Razelle Kurzrock, Apostolia M. Tsimberidou, Rajyalakshmi Luthra, J. Jack Lee, Sarina A. Piha-Paul, Siqing Fu, Vanda M. Stepanek, David S. Hong, Gerald S. Falchook, Aung Naing, Jennifer J. Wheler, Filip Janku |
|---|---|
| Rok vydání: | 2023 |
| DOI: | 10.1158/0008-5472.22396493.v1 |
| Popis: | PDF file - 70K, Co-existing PIK3CA and KRAS mutations |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|